Cinqair
Reslizumab · Teva Respiratory, LLC
PRESCRIPTION ONLY (USA)Cinqair ingredients
| Active ingredient | Strength |
|---|---|
| Reslizumab | 10 mg/mL |
What Cinqair is used for
Cinqair is a specialist medicine (interleukin-5 antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Cinqair
- Generic name
- Reslizumab
- Made by
- Teva Respiratory, LLC
- Forms
- Injection, Solution, Concentrate
- Given
- Intravenous
- Drug class
- Interleukin-5 Antagonist
- FDA approval
- Biologic licence (BLA) BLA761033
- On the US market since
- 2016
Official information
- Cinqair prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Reslizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cinqair?
Cinqair (Reslizumab) is a specialist medicine made by Teva Respiratory, LLC, approved by the US FDA.
What are the ingredients of Cinqair?
Cinqair contains Reslizumab (10 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA